MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Plasma-based circulating long non-coding RNA AS-Uch1 as a novel diagnostic biomarker for Parkinson’s disease

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aimed to validate plasma-based circulating long non-coding RNA (lncRNA) as biomarker for the diagnosis of Parkinson's disease (PD). Background: Parkinson's disease (PD) is…
  • 2019 International Congress

    Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aims to explore the expression profiles of lncRNA of PD patients and its roles to the pathogenesis of PD. Background: The molecular…
  • 2019 International Congress

    Cognition and Gait in Parkinson’s Disease

    A. Fatima (Lahore, Pakistan)

    Objective: Evaluating DT situations in Parkinson Disease is helpful since cognitive functions and motor control—both often impaired in PD—are examined at the same time. However,…
  • 2019 International Congress

    Deep Brain Stimulation as second line advanced treatment for PD after LCIG

    A. Faust-Socher, F. Abu Ahmad, N. Giladi, A. Hilel, Y. Shapira, D. Klepikov, A. Ezra, L. Raif, T. Gurevich (Tel Aviv, Israel)

    Objective: Staging of advanced treatments for Parkinson's disease such as levodopa–carbidopa intestinal gel infusion (LCIG) and Deep brain stimulation (DBS) Background: Device-aided therapies for Parkinson’s…
  • 2019 International Congress

    Quantitative Assessment of Saccadic Eye Movements in Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease

    C. Fearon, Y. Llamas-Osorio, L. Williams, A. Laffan, P. Moloney, R. Field, R. Reilly, T. Lynch (Dublin, Ireland)

    Objective: To investigate whether quantitative assessment of saccadic eye movements can distinguish between patients with progressive supranuclear palsy from patients with idiopathic Parkinson’s disease. Background:…
  • 2019 International Congress

    Modifiable factors and progression of motor symptoms and cognitive decline in Parkinson’s disease

    E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)

    Objective: To determine the association between potentially modifiable factors including (1) cardiovascular risk factors (2) neuropsychiatric symptoms, and (3) sleep quality and progression of motor…
  • 2019 International Congress

    Interleaving stimulation in Parkinson’s disease: interesting to whom?

    C. França, E. Barbosa, R. Iglesio, M. Teixeira, R. Cury (São Paulo, Brazil)

    Objective: Overview our patients’ experience with ILS and explore clinical scenarios in which ILS should be considered when programming DBS in PD patients. Background: Interleaving…
  • 2019 International Congress

    Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease

    S. Franthal, L. Pirpamer, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, F. Fazekas, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: The aim of our study was to determine the diagnostic value of nigral iron depositions in PD, measured by iron specific MRI-techniques. Background: Nigral…
  • 2019 International Congress

    Clinical patterns of gait freezing in Parkinson’s disease and their response to interventions: an observer-blinded study

    O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)

    Objective: To evaluate the occurrence and severity of FOG in provoking situations during a standard video-recorded walking task. To use this method to compare the effects…
  • 2019 International Congress

    Spin turns and step turns in advanced Parkinson’s disease: a new clinical gait sign?

    O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)

    Objective: To evaluate which approach patients with Parkinson’s disease (PD) choose when they change direction of walk and if L-dopa and subthalamic nucleus deep brain…
  • « Previous Page
  • 1
  • …
  • 1278
  • 1279
  • 1280
  • 1281
  • 1282
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley